- email:professionalcustserv@informa.com
- phone:+44 (0) 20 7017 5503
 |
IBC Legal's 21st Annual
Biotech & Pharmaceutical Patenting 2013
26 - 27 February 2013
|
The 21st Anniversary Biotech & Pharmaceutical Patenting Conference 2013: Protecting and maximising medical innovation
Get up to date with this complex sector's key legal issues and gain commercial insights into how to surmount the practical challenges that Biotech & Pharmaceutical Patenting poses.
Tackling a broad spectrum of issues at a high level, this in-depth and specialised conference will explain how to deal with the unusual factors and subtle nuances that can arise.
Led by an unrivalled panel of legal advisors this event will bring you the most cutting edge guidance with representatives from the EPO and the EC and perspectives from industry!
Craft your patent claims and specifications with this effective interpretation of the requirements and restrictions.
Find out more on the latest agenda for the Biotech & Pharmaceutical Patenting conference 2013.
Just some of the companies that have previously attended this essential event!
Philip Morris Products - BioGeneriX -Transgene -Fujifilm -Clavis Pharma -Merck Serono -Teva Pharmaceutical Industry -Oxford Immunotec -Synthon -Int'l Patent Bureau -IMS Health -DSM Nutritional Products -Sanofi Pasteur -Astrazeneca R&D -Actelion Pharmaceuticals -Institut Francais Du Petrole -Ivax Pharmaceuticals -F Hoffmann-La Roche -Micromet -Helsinn Healthcare -Fibrogen Inc -United Trademark & Patent Services -Robert Bosch -Philips -Novozymes -Pliva Research Institute -British American Tobacco Investments -Unipath -Merial -Novo Nordisk -Saudi Food & Drug Authority - Bioinvent Int'l -Nony & Partners -Solvay Pharmaceuticals -Sagem Defense Securite -Novartis Pharma -Zacco Norway -Cambridge Antibody Technology -Norwegian Industrial Property Office -Innate Pharma -Al-Hikma Pharmaceuticals -Pfizer
Expert speakers at the 2013 Biotech & Pharma Patenting Conference:
Perspectives from Regulators, Corporates & Advisers:
- Henri Piffaut, DG Competition, European Commission
- Heli Pihlajamaa, Director Patent Law, European Patent Office
- Juergen Dressel, Head of Patent Litigation ex USA, Novartis Pharma AG
- Tom Bombelles, Global Challanges Division, WIPO
- Dr. Hans Masselink, Senior Patent Attorney Pharma Intellectual Property, Novartis Pharma AG
- Robert Burrows, Partner, Bristows
- Gustavo de Freitas Morais, Partner, Dannemann Siemsen Advogados
- Liz Cohen, Partner, Bristows
- Bert Oosting, Partner, Hogan Lovells LLP
- Dr. Henrik Holzapfel, Associated Partner, Gleiss Lutz Rechtsanwälte
- Zarina Iqbal, Head of Patent Department, United Trade Mark and Patent Services
- Dr. Anna Wolters, Partner, Bird & Bird LLP
- Dr. Penny Gilbert, Partner, Powell Gilbert LLP
- Prof. Dr. Christian Dierks, Rechtsanwalt, Dierks + Bohle Attorneys
- Dr. Christopher Stothers, Partner, Arnold Porter (UK) LLP
- Kevin Mooney, Partner, Simmons & Simmons LLP
- Peter De Weerd, Partner, Plougmann & Vingtoft AG
- Christine Kanz, Partner, Reimann Osterrieth Kohler Haft
- Howard Rosenberg, Partner, Frommer Lawrence & Haug LLP
- Dr. Hugh Goodfellow, Partner, Carpmaels & Ransford
- Dr. Thomas Reimann, Partner, Reimann Osterrieth Kohler Haft
- Dr. Arwed Burrichter, Partner, Cohausz & Florack Patentanwälte
- Pierre Véron, Avocat, Véron & Associés
- Kim Wagner, Partner, Plougmann & Vingtoft
Key reasons to attend the upcoming Biotech & Pharmaceutical Patenting event
UPDATES
- Developments in European Patent Law in the Last 12 months
TACTICS
- Tactical Patenting
- Patenting Genes and Theranostics including HGS V Lilly
- General Principles Relating to Biological Material
- Guidelines on Non-Clinical and Clinical Issues for Authorising Biosimilars
- Personalised Medicines – What can you Achieve?
DEVELOPING COUNTRIES
- Transporting Patents to Developing Countries – including Gustavo de Freitas Morais of Brazil and with Zarina Iqbal of Pakistan
ISSUES & SOLUTIONS
- Dealing with Competition Law issues in Patenting
- Product Launch Strategies and Preliminary Injunctions including the Solvay case
- Planning for Patent Expiry and Managing Innovation
- Defending a Market
- CASE STUDY in Patents - including protecting patents on a budget
- Biotechnical and Pharmaceutical Patenting in the US Market
REGULATORY ISSUES
- The Unified Patent Court – What Will be its Impact?
- Second Medical Use and Dosing Regimens Claims in the UK and at the EPO - Infringement by Off-Label Use
- Bolar and Research/Experimental Use Exemptions
- SPCs Masterclass - Recent Case Law and Varying Requirements around Europe including an Analysis of the Impact of Neurim
- Strategies for Maximising Patent Life Cycles - Exploring The Application Of SPCs to Extend Patents
Associate Sponsors:
Supported By:
Drinks Sponsor:
Media Partners:
Feeds | Like | Share    | Calendar |
Download Latest Information Now
(updated 18 May 2013)
What do your peers think of Biotech & Pharmaceutical Patenting?
"All you need to know in biotech and pharma: annual update!"
Also available...
From King's College London: Postgraduate Diploma/Masters in
UK, EU & US Copyright Law
